Ishihara, H., Yamaguchi, S., Sugitani, T., & Kosakai, Y. (2019). Open-Label Study to Assess the Efficacy of Ipragliflozin for Reducing Insulin Dose in Patients with Type 2 Diabetes Mellitus Receiving Insulin Therapy. Clin Drug Investig.
Citação norma ChicagoIshihara, Hisamitsu, Susumu Yamaguchi, Toshifumi Sugitani, and Yoshinori Kosakai. "Open-Label Study to Assess the Efficacy of Ipragliflozin for Reducing Insulin Dose in Patients With Type 2 Diabetes Mellitus Receiving Insulin Therapy." Clin Drug Investig 2019.
MLA citiranjeIshihara, Hisamitsu, Susumu Yamaguchi, Toshifumi Sugitani, and Yoshinori Kosakai. "Open-Label Study to Assess the Efficacy of Ipragliflozin for Reducing Insulin Dose in Patients With Type 2 Diabetes Mellitus Receiving Insulin Therapy." Clin Drug Investig 2019.